Midriff bulge linked to heightened risk of sudden, often fatal, heart malfunction

December 10, 2014

Those with the largest waists and hips combined are twice as likely to be affected as those with measurements in the normal range, the findings indicate.

Sudden cardiac death, or SCD for short, occurs without warning, and is caused by a sudden unexpected loss of heart function, which rapidly reduces blood flow around the body, including to the brain. It is distinct from a heart attack, and kills around 300,000 people in the USA every year.

Obesity has long been associated with various unfavourable changes in cardiovascular health, including SCD. But the researchers wanted to find out if a persistent midriff bulge may carry a greater risk of SCD than general obesity as the evidence suggests this body fat distribution may be more dangerous.

They therefore studied almost 15,000 middle aged men and women (45-64 years of age), all of whom were taking part in the Atherosclerosis Risk in Communities (ARIC) study.

ARIC has been tracking the causes of artery narrowing in middle aged Americans since 1987.

All the participants (55% women; 26% African American) underwent a detailed health assessment in 1987-9, and then again in 1990-92, 1993-5, 1996-8, and 2011-13. This included measurements of weight, height, waist circumference, and the waist to hip ratio.

During the monitoring period, which averaged 12.5 years, 253 SCDs occurred. Those affected were in their mid-fifties, on average; one in three was female; and four out of 10 were of African American heritage.

Unsurprisingly, those who died suddenly tended to have a higher prevalence of known risk factors for cardiovascular disease, such as high blood pressure and high cholesterol.

They also had a higher BMI (body mass index), larger waist circumference, and a larger waist to hip ratio--an indicator of central obesity--than those who did not sustain an SCD.

The risk of SCD was associated with general obesity, but only in non-smokers. And of the measures of obesity--BMI, waist circumference, and waist to hip ratio--waist to hip ratio was the most strongly associated with SCD risk after taking account of other influential factors.

Those with the highest waist to hip ratio had double the risk of SCD of those with a normal ratio.

And unlike BMI and waist circumference, the association between waist to hip ratio was independent of existing coronary heart disease, diabetes, or high blood pressure and other known risk factors.

This is an observational study so no definitive conclusions can be drawn about cause and effect, added to which the precise mechanisms for the association between SCD and central obesity are not known, say the researchers.

But fat around the midriff is thought to be more critical than fat stored elsewhere in the body, because of its influence on inflammation.
-end-


BMJ

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.